COMUNICATO STAMPA SPONSORIZZATO – Angel Yeast’s 8,500-Ton Specialty Yeast Facility and New Brewing Microbial Pilot Platform Come Online

(Immediapress) – YICHANG, China, Nov. 28, 2025 /PRNewswire/ — Angel Yeast (SH600298), a global leader in yeast and fermentation solutions, has begun trial production at its new specialty yeast project in the Baiyang Biotechnology Park, Yichang High‑tech Zone. The facility commenced material feeding on August 31 and, once fully ramped, will reach an annual capacity of 8,500 tons. This launch completes Angel Yeast’s full-chain layout in specialty yeast—from R&D and pilot‑scale production to scaled manufacturing—enhancing supply of high-value yeast‑derived ingredients for craft brewing, wine, and bioenergy, and strengthening the biomanufacturing value chain.

“The microbiological standard for specialty yeast is at the ten-thousand level, meaning significantly fewer contaminants. Filtered air enters pressurized feeding tanks to maintain positive pressure, ensuring nitrogen, phosphorus, potassium, and other nutrients remain in a highly sterile storage environment,” said Qin Benguo, Assistant Director of Specialty Yeast Production at Angel Yeast’s Yichang High‑tech subsidiary.

Core lines feature full-process automation from feeding and fermentation to packaging and storage, supporting stable, reproducible quality at scale.

With broader application scope than conventional baker’s yeast, Angel’s specialty yeast targets high-value segments: craft beer, wine and other alcoholic beverages, fuel ethanol, and biomass energy. By delivering stable, premium raw materials at scale, the new capacity will help brewers and bioenergy producers improve yields, enhance process stability, and advance flavor and performance consistency—key for accelerating product innovation and market expansion.

Angel Yeast Commissions Brewing Functional Microorganism Pilot Test Platform

Complementing the new production line, Angel Yeast has also commissioned its Brewing Functional Microorganism Pilot Test Platform, designed to bridge lab discoveries and industrial‑scale validation. The platform simulates real-world brewery environments, addressing the limitations of on-line trials—such as inconsistent operator practices and imprecise timing—by delivering reproducible, data-driven results under factory-like conditions. Equipped with real-time monitoring, it tracks microbial dynamics and flavor compound evolution, enabling precise quality assessment, faster R&D iteration, and optimized technical schemes for partners.

“Equipped with real‑time monitoring systems, the platform allows us to track microbial dynamics and flavor compound evolution in a controlled, factory-like setting,” said Luo Xinjie, Director of Brewing Technical Support at Angel Yeast’s Food & Fermentation Business Unit. “This enables us to assess product quality with unprecedented precision, refine R&D directions, and optimize technical schemes for our partners.”

In the baijiu sector alone, Angel’s solutions have already helped boost yield, enhance fermentation stability, and enable precise flavor control. With the pilot platform, the cycle from R&D to industrial application can be significantly shortened, allowing breweries to access tailored, validated solutions faster—reducing time‑to‑market and improving operational efficiency.

Together, the 8,500‑ton specialty yeast facility and the Brewing Functional Microorganism Pilot Platform form a powerful engine for global biomanufacturing and brewing innovation. As Angel Yeast expands its capabilities—from clean, automated specialty yeast production to translational pilot testing—the company is poised to deliver more functional, sustainable solutions and inject fresh momentum into bio‑based products worldwide.

Photo – https://mma.prnewswire.com/media/2834157/2.jpgPhoto – https://mma.prnewswire.com/media/2834156/1.jpgLogo – https://mma.prnewswire.com/media/1586948/angel_logo_Logo.jpg 

View original content:https://www.prnewswire.co.uk/news-releases/angel-yeasts-8-500-ton-specialty-yeast-facility-and-new-brewing-microbial-pilot-platform-come-online-302628062.html

COMUNICATO STAMPA SPONSORIZZATO: Immediapress è un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. L’Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi